Skip to the page

Data / Drug companies / Carbamazepine

Carbamazepine: 52 companies and 154 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Carbamazepine is listed in the FDA National Drug Code Directory by 52 companies, with 154 products in commercial distribution. 143 of the products (92.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, extended release; tablet; capsule, extended release, and the newest product started marketing on October 9, 2026.

The request: Get every company that lists carbamazepine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
52
Products
154
Generic (ANDA) products
143 (92.9%)
Application numbers
33
Routes
Oral
Brand names
Equetro, Carbatrol, Tegretol XR, Tegretol, Carbamazepin
openFDA record search
api.fda.gov

Companies that list carbamazepine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Remedyrepack Inc.11tablet; tablet, extended releaseGeneric drugs (ANDA)June 25, 2026
Bryant Ranch Prepack9capsule, extended release; tabletGeneric drugs (ANDA)April 21, 2020
Sun Pharmaceutical Industries, Inc.7tablet, extended release; tablet, chewableGeneric drugs (ANDA)March 31, 2009
Coupler LLC6capsule, extended release; tabletGeneric drugs (ANDA)June 16, 2026
Novartis Pharmaceuticals Corporation5tablet, extended release; suspensionNew drug applications (NDA)March 25, 1996
Torrent Pharmaceuticals Limited5tablet, extended release; tablet, chewableGeneric drugs (ANDA)September 10, 2025
Umedica Laboratories USA Inc.5tablet, extended release; tabletGeneric drugs (ANDA)August 20, 2022
Alembic Pharmaceuticals Inc.4tablet, film coated, extended release; tabletGeneric drugs (ANDA)July 26, 2025
Alembic Pharmaceuticals Limited4tablet, film coated, extended release; tabletGeneric drugs (ANDA)July 26, 2025
American Health Packaging4tablet, extended release; tablet, chewableGeneric drugs (ANDA)September 29, 2026
Apotex Corp.4capsule, extended release; tabletGeneric drugs (ANDA)March 23, 2012
AvPAK4capsule, extended release; tabletGeneric drugs (ANDA)October 13, 2025
Golden State Medical Supply, Inc.4tablet, extended release; tabletGeneric drugs (ANDA)March 31, 2009
Ajanta Pharma USA Inc.3tablet, extended releaseGeneric drugs (ANDA)March 24, 2023
Ani Pharmaceuticals, Inc.3capsule, extended releaseGeneric drugs (ANDA)April 13, 2026
Ascend Laboratories, LLC3tablet, extended releaseGeneric drugs (ANDA)November 1, 2025
Bostal LLC3tablet, extended releaseGeneric drugs (ANDA)March 31, 2022
Bryant Ranch Prepack3capsule, extended release; tabletGeneric drugs (ANDA)March 23, 2012
Epic Pharma, LLC3tablet, extended releaseGeneric drugs (ANDA)June 3, 2024
Ingenus Pharmaceuticals, LLC3tablet, extended releaseGeneric drugs (ANDA)August 1, 2023
Jubilant Cadista Pharmaceuticals Inc.3tablet, extended releaseGeneric drugs (ANDA)August 20, 2022
Major Pharmaceuticals3tablet; capsule, extended releaseGeneric drugs (ANDA)March 23, 2012
NorthStar RxLLC3tablet, extended releaseGeneric drugs (ANDA)February 24, 2026
Rising Pharma Holdings, Inc.3tablet, extended releaseGeneric drugs (ANDA)April 24, 2020
Takeda Pharmaceuticals America, Inc.3capsule, extended releaseNew drug applications (NDA)December 22, 1999
Upsher-Smith Laboratories, LLC3tablet, extended releaseGeneric drugs (ANDA)April 13, 2021
Validus Pharmaceuticals LLC3capsule, extended releaseNew drug applications (NDA)December 10, 2004
Zydus Lifesciences Limited3tablet, extended releaseGeneric drugs (ANDA)March 12, 2019
Zydus Pharmaceuticals USA Inc.3tablet, extended releaseGeneric drugs (ANDA)March 12, 2019
A-S Medication Solutions2tabletGeneric drugs (ANDA)April 21, 2020
Bryant Ranch Prepack2tablet, extended release; tabletGeneric drugs (ANDA)August 20, 2022
Chartwell Governmental & Specialty RX, LLC.2suspensionGeneric drugs (ANDA)June 5, 2002
Chartwell RX, LLC2suspensionGeneric drugs (ANDA)June 5, 2002
Golden State Medical Supply, Inc.2tablet; tablet, chewableGeneric drugs (ANDA)February 27, 2002
NCS HealthCare of Ky, LLC DBA Vangard Labs2tablet; tablet, chewableGeneric drugs (ANDA)October 24, 2000
Nivagen Pharmaceuticals, Inc.2tabletGeneric drugs (ANDA)April 21, 2020
NorthStar Rx LLC2tablet, extended releaseGeneric drugs (ANDA)February 1, 2021
Oryza Pharmaceuticals Inc.2tablet, extended releaseGeneric drugs (ANDA)May 18, 2026
Precision Dose, Inc.2suspensionGeneric drugs (ANDA)October 9, 2026
Preferred Pharmaceuticals Inc.2tabletGeneric drugs (ANDA)January 8, 2021
American Health Packaging1tabletGeneric drugs (ANDA)June 2, 2023
Ani Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)October 6, 2022
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)October 3, 1996
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)March 7, 2014
Atlantic Biologicals Corp.1suspensionGeneric drugs (ANDA)September 20, 2004
Bionpharma Inc.1tabletGeneric drugs (ANDA)March 15, 2024
Cardinal Health 107, LLC1tabletGeneric drugs (ANDA)September 20, 2010
Direct_Rx1tabletGeneric drugs (ANDA)December 1, 2020
NuCare Pharmaceuticals,Inc.1tabletGeneric drugs (ANDA)November 1, 2022
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)October 3, 1996
Proficient Rx LP1tabletGeneric drugs (ANDA)September 1, 2002
Unichem Pharmaceuticals (USA), Inc.1tabletGeneric drugs (ANDA)November 1, 2022

Dosage forms

Dosage formProductsShare
Tablet, extended release6039%
Tablet4026%
Capsule, extended release2717.5%
Tablet, chewable117.1%
Suspension106.5%
Tablet, film coated, extended release63.9%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)14392.9%
New drug applications (NDA)117.1%

Pharmacologic classes

ClassProducts
Mood Stabilizer154

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.